Allergy Shot Build-Up Schedule: Doses, Intervals, and Variants
The SCIT build-up schedule is the 3–6-month weekly escalation phase where allergen extract doses increase from the most dilute vial to the maintenance concentration. Conventional: approximately 24–28 weekly visits, single injection per visit, escalating 0.05–0.10 mL to ~0.5 mL over five serial dilutions per Cox 2011 PP3. Cluster compresses to 4–8 weeks; rush to 1–3 days. Tkacz 2021: 23.9% of AIT patients never return after the first injection — build-up is the structural bottleneck where most SCIT patients fail.
7 peer-reviewed sources
Conventional allergy shot build-up takes 24–28 weekly visits over 3–6 months, escalating doses from 0.05–0.10 mL of the most dilute vial to approximately 0.5 mL of the maintenance concentrate. Cluster compresses to 4–8 weeks; rush to 1–3 days.
The essentials
The SCIT build-up schedule is the 3–6-month escalation phase where the patient progresses through serially diluted aliquots of their allergen extract toward the maintenance concentration. Per Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1–S55 (DOI 10.1016/j.jaci.2010.09.034), the conventional weekly cadence is 1–2 injections per week, single injection per visit, over approximately 24–28 visits.
Curex pairs at-home IgE testing with board-certified allergist review to identify which allergens drive a patient's symptoms — the diagnostic step before any decision about a 24–28-visit build-up schedule.
Dose ladder per Cox 2011: build-up starts at 0.05–0.10 mL of the most dilute vial and escalates to approximately 0.5 mL of the maintenance concentrate. A representative volume progression: 0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50 mL across serial dilutions. The ACAAI mixing guide color code: silver (1:10,000), green (1:1,000), blue (1:100), yellow (1:10), red (1:1 maintenance). Patients should read the labeled concentration rather than relying on color — only 41% of US practices use the standard color-coding scheme per Prudenti 2023.
Missed-dose management is one of the most-asked questions during build-up. Per Cox 2011 PP3 interval-based dose-adjustment tables, build-up intervals are commonly 3–10 days. Exceeding approximately 10–14 days typically triggers a dose reduction — the prior lower dose is repeated before resuming escalation. The longer the gap, the larger the reduction.
Mandatory 30-minute observation after every build-up injection per Cox 2011 — approximately 70% of fatal and systemic reactions to SCIT onset within that window. Per Epstein TG et al., Ann Allergy Asthma Immunol 2013 (PMID 23535092), the systemic-reaction rate is 0.1% per injection visit.
Build-up alternatives: cluster compresses to 4–8 weeks with 2–4 injections per visit at ≥30-minute intervals (Tabar AI et al., JACI 2005;116:109–118 — equivalent efficacy, higher per-injection reaction rate); rush compresses to 1–3 days with multiple injections over hours (Bernstein DI et al., JACI 2008 — systemic reaction rate up to >36% vs. <1% conventional per PMID 8977545).
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
SCIT has three phases. The build-up phase is Phase 1 — the only phase where the schedule is weekly and the dose is escalating. After build-up, the schedule extends to every 2–4 weeks for the 3–5-year maintenance phase. Understanding all three phases sets realistic expectations before the first injection.
Dose ladder: 0.05–0.10 mL of silver-cap 1:10,000 vial, escalating through green (1:1,000), blue (1:100), yellow (1:10), to approximately 0.5 mL of red-cap 1:1 maintenance concentrate per Cox 2011 PP3. Mandatory 30-min observation per visit. Missed-dose rule: exceeding approximately 10–14 days between injections typically triggers a dose reduction per Cox 2011. Cluster alternative: Tabar 2005 JACI (equivalent efficacy, 4–8 weeks). Rush alternative: Bernstein 2008 JACI (1–3 days, >36% systemic reaction rate possible).
Once the maintenance dose (~0.5 mL of the red-cap concentrate) is reached, the interval extends to every 2–4 weeks for 3–5 years per Cox 2011. The 30-minute observation continues unchanged. Durham SR et al., NEJM 1999;341:468–475 showed 3 years of maintenance yields 4 years of post-discontinuation remission — the payoff for completing build-up.
Completing the full build-up + maintenance course yields durable 4+ year remission per Durham 1999 NEJM. PAT 10-year follow-up (Jacobsen 2007 Allergy) extends pediatric benefit to prevention of new sensitizations and asthma. No biomarker reliably predicts post-discontinuation relapse — the decision is clinical.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Conventional, cluster, and rush represent the three SCIT build-up options. With at-home SCIT, eligible maintenance patients self-administer the same weekly shot at home after the supervised early doses — and SLIT drops are a separate home-based route that uses no injection build-up at all.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Conventional build-up (weekly) | |||||
Cluster build-up (4–8 weeks) | |||||
Rush build-up (1–3 days) | |||||
SLIT drops (at-home daily) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients who cannot commit to 24+ weekly clinic visits during build-up, Curex delivers the SCIT shot itself at home — at-home subcutaneous immunotherapy as one weekly self-administered injection at $129/month, a serum sterile-compounded to USP <797> standards and overseen by a board-certified allergist, with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand, so eligible maintenance patients escape the in-clinic build-up grind.
See if at-home shots are right for youFrequently asked questions
How long is the allergy shot build-up phase?
The conventional SCIT build-up phase takes approximately 3–6 months, involving 24–28 weekly visits with a single injection per visit, per Cox L et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1–S55 (DOI 10.1016/j.jaci.2010.09.034). Medicare LCD L36240 describes it as 'anywhere from 8–28 weeks to achieve a maintenance dose.' Cluster build-up compresses this to 4–8 weeks with 2–4 injections per visit at ≥30-minute intervals (Tabar AI et al., JACI 2005;116:109–118 — equivalent efficacy). Rush build-up compresses it further to 1–3 days (Bernstein DI et al., JACI 2008) with higher systemic-reaction risk. After build-up, all three protocols transition to the same maintenance schedule: every 2–4 weeks for 3–5 years.
What is the dose ladder for SCIT build-up?
Per Cox 2011 PP3, SCIT build-up starts at 0.05–0.10 mL of the most dilute vial and escalates to approximately 0.5 mL of the maintenance concentrate. A representative volume ladder: 0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50 mL, progressing through five serially diluted vials. The ACAAI mixing guide color code: silver (1:10,000), green (1:1,000), blue (1:100), yellow (1:10), red (1:1 maintenance). Patients should read the concentration label on each vial rather than relying solely on the color, as only 41% of US practices use the standard color-coding scheme per Prudenti 2023. The specific ladder varies by clinic and allergen type.
What happens if I miss a build-up allergy shot appointment?
Missed-dose management during SCIT build-up follows the Cox 2011 PP3 interval-based dose-adjustment tables. Build-up intervals are commonly 3–10 days. Exceeding approximately 10–14 days typically triggers a dose reduction — the prior lower dose is repeated before resuming escalation. A gap of several weeks may require returning to the prior dilution series entirely. The longer the gap, the larger the required dose reduction. Patients should notify their allergist before any known scheduling gap so that a reduced-dose vial can be prepared. The goal of the dose-reduction protocol is to maintain safety — restarting at a lower dose after a gap reduces the risk of a systemic reaction.
What is the systemic reaction risk during allergy shot build-up?
Per Epstein TG et al., Ann Allergy Asthma Immunol 2013 (PMID 23535092), the systemic-reaction rate during SCIT is 0.1% per injection visit across all phases — 7.1 grade 1, 2.6 grade 2, 0.4 grade 3 systemic reactions per 10,000 injection visits. One confirmed fatality occurred per 23.3 million injection visits during 2008–2012. Build-up is the highest-risk phase because doses are escalating. The WAO Systemic Reaction Grading System (Cox L et al., JACI 2010;125:569–574) classifies reactions from grade 1 (mild rhinitis/urticaria) to grade 5 (death). If throat tightness, breathing difficulty, generalized hives, or lightheadedness occur after an injection, call 911 immediately and use epinephrine if available.
Is cluster build-up safer than conventional for allergic patients?
No — cluster build-up carries higher systemic-reaction risk than conventional weekly build-up. A clinical-practice series found 10.9% of cluster patients experienced a systemic reaction during build-up. A Johns Hopkins comparative analysis found the per-injection systemic-reaction rate is more than 3-fold higher than conventional — overall patient-level rates 37% cluster vs. 21% standard (P = 0.084). Bernstein DI et al., J Allergy Clin Immunol 2008 surveillance confirmed cluster and rush are both associated with increased systemic-reaction risk. Cluster is appropriate for motivated patients who cannot manage the 24–28-week conventional schedule and who have stable, well-controlled asthma and no beta-blocker use.
How does rush allergy shot build-up differ from cluster?
Rush build-up compresses the SCIT escalation into 1–3 days, compared to cluster's 4–8 weeks. Rush involves multiple injections over hours on a single or consecutive days, achieving maintenance or near-maintenance in that compressed window. Per a classic review (PMID 8977545), the systemic-reaction rate ranges from '<1% conventional to >36% rush.' Cluster averages 19.3 weeks to maintenance vs. 16.5 weeks for rush in a retrospective comparison — showing rush is only marginally faster while carrying substantially higher risk. Rush is not the same as ultra-rush (hours), which is primarily used for Hymenoptera venom immunotherapy (Müller/Brockow PMID 16689180). Rush requires full-day clinic supervision, premedication, and staff prepared to manage anaphylaxis.
Why do so many patients fail to complete allergy shot build-up?
Real-world data from Tkacz JP et al., Curr Med Res Opin 2021;37(6):957–965 (DOI 10.1080/03007995.2021.1903848) found that 23.9% of 103,207 AIT patients never returned after the first injection and only 43.9% reached the maintenance phase. The conventional weekly build-up schedule — 24–28 separate clinic visits each requiring a 30-minute wait — is the dominant adherence barrier. Contributing factors include limited allergist access (Wu I et al., AAAAI 2019: 81.5% of US counties have zero allergists), work schedule inflexibility, transportation barriers, and early post-injection discomfort. Discussing schedule alternatives before starting is clinically appropriate for patients with known schedule constraints — cluster or rush build-up, SLIT, or at-home SCIT, which Curex delivers as one weekly self-administered shot for $129/month with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand, removing the recurring-clinic-visit barrier behind that dropout.
How does SLIT compare to SCIT during build-up?
Sublingual immunotherapy (SLIT) has no equivalent 'build-up clinic phase.' FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek, Odactra) require only a single supervised first dose in a clinical setting, then daily self-administration at home. Compounded SLIT drops follow the same model. SLIT achieves disease modification through daily allergen exposure at the oral mucosal surface rather than weekly escalating subcutaneous injections. The practical difference is 24–28 clinic visits for SCIT build-up vs. one supervised first dose for SLIT. SLIT carries a substantially lower systemic-reaction profile than SCIT per Cox 2011 PP3 SLIT supplement — it is designed for daily home use rather than in-clinic escalation.
Related Articles
Allergy Shot Name: SCIT Defined & Explained | Curex
The clinical name for an allergy shot is subcutaneous immunotherapy (SCIT). There is no single brand name — each vial is custom-compounded. SLIT tablets have brand names; SCIT does not.
Read moreAllergy Shot Maintenance Schedule: Cox 2011 Guide | Curex
Allergy shot maintenance: every 2–4 weeks for 3–5 years at ~0.5 mL. 30-min observation continues. Missed-dose rules, Durham 1999 durability, and 42–130 lifetime visit math.
Read moreAllergy Injections Guide: Schedule & Safety | Curex
Allergy injections (SCIT) mean 60-80+ visits over 3-5 years. Cochrane 51 RCTs: SMD -0.73. Learn what goes in the vial, the schedule, and real-world adherence data.
Read moreCluster Allergy Shots: Schedule & Safety | Curex
Cluster allergy shots reach maintenance in 4–8 weeks vs 6 months. Schedule, the 3× higher per-injection reaction rate, and who qualifies (Tabar 2005).
Read moreMonthly Allergy Shots: Maintenance Schedule Guide | Curex
SCIT maintenance shots — every 2-4 weeks for 3-5 years after build-up. Durham 1999 NEJM: 3 years yields 4 years of remission. Missed-dose rules inside.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.